One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the PancreasThe A021501 Phase 2 Randomized Clinical Trial
Matthew H. G. Katz, MD; Qian Shi, PhD; Jeff Meyers, BS; et al.
doi : 10.1001/jamaoncol.2022.2319
September 2022, Vol 8, No. 9, Pages 1248-1364
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast CancerThe Neo-PATH Phase 2 Nonrandomized Clinical Trial
Hee Kyung Ahn, MD; Sung Hoon Sim, MD, PhD; Koung Jin Suh, MD, MS; et al.
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant IntentA Phase 2 Measurable Residual Disease–Adapted Study
Benjamin A. Derman, MD; Ankit Kansagra, MD; Jeffrey Zonder, MD; et al.
Global Association of COVID-19 Pandemic Measures With Cancer ScreeningA Systematic Review and Meta-analysis
Federica Teglia, MD; Marco Angelini, MD; Laura Astolfi, MD; et al.
Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology TrialsA Systematic Review and Meta-analysis
Pralay Mukhopadhyay, PhD; Jiabu Ye, PhD; Keaven M. Anderson, PhD; et al.
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China
Han Qiao, PhD; Xi-Rong Tan, MD; Hui Li, MA; et al.
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
Natansh D. Modi, BPharm (Hons); Ahmad Y. Abuhelwa, PhD; Ross A. McKinnon, PhD; et al.
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
Panagiotis A. Konstantinopoulos, MD, PhD; Allison A. Gockley, MD; Niya Xiong, MS; et al.
Evaluation of the Molecular Landscape of Pediatric Thyroid Nodules and Use of a Multigene Genomic Classifier in Children
Jean-Nicolas Gallant, MD, PhD; Sheau-Chiann Chen, PhD; Carlos A. Ortega, BS; et al.
Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA TestingA Phase 2 Nonrandomized Clinical Trial
Jiachen Xu, MD; Zheng Liu, MD; Hua Bai, MD; et al.
Environmental Outcomes Associated With Transition From In-Person to a Virtual Oncology Conference During the COVID-19 Pandemic
Katie E. Lichter, MD, MPH; Taylor Drew, BA; Sasha Demeulenaere, BS; et al.
Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy
Catherine Young Han, BS; Conall Fitzgerald, MD, MSc; Mark Lee, MD; et al.
Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018
Connor J. Kinslow, MD; Arreum Kim, MS, MSBS; Gloria I. Sanchez, PhD; et al.
Daily Insulin Dose and Cancer Risk Among Patients With Type 1 Diabetes
Wenjun Zhong, PhD; Yuanjie Mao, MD, PhD
A New Approach to Simplifying and Harmonizing Cancer Clinical Trials—Standardizing Eligibility Criteria
David E. Gerber, MD; Harpreet Singh, MD; Erin Larkins, MD; et al.
Treatment of Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia—From Intensive Chemotherapy Combinations to Chemotherapy-Free RegimensA Review
Elias Jabbour, MD; Fadi G. Haddad, MD; Nicholas J. Short, MD; et al.
Asymptomatic Cutaneous Plaques on the Scalp and Face in an Older Adult Woman
Xuemei Lan, MD; Hao Chen, MD; Yiqun Jiang, MD
Starting a Career in OncologyFighting Cancer and Gender Disparities
Johanna E. Poterala, MD; Narjust Duma, MD
Brain Metastasis—A Distinct Oncologic Disease Best Served by an Integrated Multidisciplinary Team Approach
Nelson S. Moss, MD; Kathryn Beal, MD; Viviane Tabar, MD
Research During Wartime—Ethical Challenges Faced by Oncology Researchers in Ukraine
Maksym Basarab, MD; Emily E. Anderson, PhD, MPH
The Continued Struggle for Defining a Role for Radiotherapy in Pancreas Cancer
Daniel H. Ahn, DO; Tanios Bekaii-Saab, MD
Novel Quadruplets and the Age of Immunotherapies in the Treatment of Newly Diagnosed Multiple Myeloma
Dickran Kazandjian, MD; Ola Landgren, MD, PhD
Perioperative Therapy in Early-Stage Lung Cancer
Aakash Desai, MBBS, MPH; Ana I. Velazquez, MD, MSc; Howard (Jack) West, MD
Role of Patient-Reported Outcome Measures in the Inpatient Setting
Abdulla Al-Rashdan, MD
Role of Patient-Reported Outcome Measures in the Inpatient Setting—Reply
Ryan D. Nipp, MD, MPH; Areej El-Jawahri, MD; Jennifer S. Temel, MD
